Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 40Lung Neoplasms 15Neoplasms 2NSCLC 2Breast Neoplasms 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor, Adult 1Sexual Dysfunction, Physiological 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-Small Cell Lung Cancer With EGFR Mutation 1Non Small Cell Lung Cancer Metastatic 1NSCLC Patients With Brain Metastasis 1Multiple Endocrine Neoplasia Type 2a 1Mesothelioma 1Meningeal Carcinomatosis 1Lung Cancer Metastatic 1Locally Advanced or Metastatic Non-squamous NSCLC 1Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC) 1Lethal Congenital Contracture Syndrome 2 1Head and Neck Neoplasms 1Eunuchism 1Erectile Dysfunction 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Advanced Solid Tumors 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 1osimertinib 1lorlatinib 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Non Small Cell Lung Cancer Metastatic × osimertinib × Clear all
NCT06741085 2026-04-13

A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
56 enrolled
Thoracic

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡